The Global Bioreactors Market size reached USD 7 bn in 2021 and is expected to register CAGR of around 13.5% between 2022 and 2030.
A bioreactor is defined as a manufacturing device or vessel in which biological reactions take place and is used to grow various organisms such as yeast, bacteria, or animal cells in an appropriate environment. They maintain a sustainable environment for cell growth and product formation. Bioreactors are used in the pharmaceutical and biotechnology industries to produce vaccines, antibodies, or biological products. They are also used in industrial processes to grow organisms under controlled conditions and to produce pharmaceuticals for the treatment of chronic diseases.
The demand for bioreactor systems across industries has fueled remarkable growth in the single-use bioreactor market in recent years. Prominent manufacturers are actively involved in producing single-use bioreactors to cater to the requirements of biopharmaceutical companies, research institutions, and other sectors. These manufacturers prioritize delivering cutting-edge and high-quality products to meet the escalating market needs. In addition to conventional bioreactor systems, emerging technologies such as photobioreactors have garnered attention due to their exceptional ability to utilize light as an energy source for cell culture. Wave bioreactors have also gained popularity due to their efficient mixing capabilities and user-friendly nature. Overall, the market for single-use bioreactors continues to expand, propelled by advancements in biotechnology and the growing adoption of bioreactor cell culture techniques in various applications.
Market Dynamics:
Drivers:
The growing adoption of advanced technologies to simplify complex manufacturing will boost bioreactors market demand. The segment statistics are expected to be driven by the widespread use of bioreactors in developing and manufacturing complex molecules such as nucleic acids and proteins. These are specific factors driving the market growth.
Restraints:
The bioreactor market is challenged by a lack of availability and access to various alternative bioreactor methods and a stringent regulatory environment for the systems and materials used.
This Bioreactor market report analyzes opportunities in terms of new recent developments, trade regulations, import and export analysis, production analysis, value chain optimization, market share, impact of domestic and local market participants, emerging revenue pockets, and changes in market regulations. It provides details on, strategic market growth analysis, market size, category market growth, application niches and dominance, product approvals, product launches, geographic expansion, and technological innovations in the market.
Key players:
-
Merck Group,
-
Cytiva,
-
Getinge (Applikon Biotechnology),
-
Eppendorf AG,
-
Sartorius Group
-
and Thermo Fisher Scientific
Market Segmentation:
Bioreactors Market, By Product Type
-
Single-use
-
Reusable
Bioreactors Market, By Cell
-
Mammalian cells
-
Bacterial cells
-
Yeast cells
-
Others
Bioreactors Market, By Molecule
-
Monoclonal antibodies
-
Vaccines
-
Recombinant proteins
-
Stem cells
-
Gene therapy
-
Others
Bioreactors Market, By Usage
-
Developmental, Pre-clinical and Clinical
-
Commercial Production
Bioreactors Market, By End-use
-
Research and Development Organizations
-
Biopharmaceutical Manufacturers
-
Contract Manufacturing Organizations (CMO)
Bioreactors Market, By Region
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
UK
-
France
-
Spain
-
Italy
-
Netherlands
-
Denmark
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Singapore
-
-
Latin America
-
Brazil
-
Mexico
-
-
Middle East and Africa
-
South Africa
-
UAE
-
Regional Analysis:
North America dominates the bioreactor market due to advances in life science research and development. Moreover, increasing investment and the number of biomanufacturing facilities will propel the bioreactor market growth in the region over the forecast period.
The Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023-2030 owing to a rise in chronic diseases. It also increases the demand for new biopharmaceuticals and increases the number of pharmaceutical companies.
Scope of the Report:
|
Report Metric |
Details |
|
Market Size Available For Years |
2020–2030 |
|
Base Year Considered |
2020 |
|
Forecast Period |
2021–2030 |
|
Forecast Unit |
Value (USD) |
|
Segments Covered |
Type, Deployment Model, Provider, Application, Enterprise Size, and Region |
|
Regions Covered |
North America (the U.S. and Canada), Europe (Germany, the UK, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and LAMEA (Middle East, Latin America, and Africa) |
|
Companies Covered |
|
User
Tab Content
Introduction
Our market research is an extensive, iterative process that takes into account a combination of primary and secondary research tools with the aim of minimizing deviation and producing the most precise estimate and prediction. For the future course of action, this approach meticulously outlines the actual changes and industry trends. It gives incredibly valuable data that is drawn from the insights and opinions of analysts and professionals. Our papers include in-depth research and analysis based on several factual inputs obtained from expert interviews, accurate data, and local information.
Market Size Estimation
The overall size of the market has been estimated and validated using both top-down and bottom-up methods. The sizes of other market subsegments have also been thoroughly estimated using these methodologies.
In the top-down technique, the market is divided into segments based on the percentage share of each segment. This method assisted in determining the size of each segment's market. The market size of each segment and its sub-segments was then divided into regional market sizes. This Approach helps mainly with the new Product Launch. It uses Multi-variate Regression Model coupled with Vendor based primary research inputs to forecast to the Market Size.
In the Bottom-Up approach, comprehensive study of key players has to be done wherein we add the market size of the major key players to understand the national market size which helps to determine the regional market size and eventually the complete market size. Companies annual report along with data from paid and unpaid resources like reports from government agencies and organizations like world bank provide the data for this approach.
Avail 25% Discount
Report Benefits
-
Free Customization Available
-
30% discount on your next purchase
-
Dedicated account manager
-
Query resolution within 24 hours
-
Permission to print the report